NRAS and colorectal carcinoma: Although no significant association between KRAS, NRAS, or BRAF status and age at onset of CRC was identified in our data, we did find a statistically significant correlation (p = 0.046) between the specific KRAS G12C mutation and patients younger than 50 years.